Vol 16, No 1 (February 28, 2025): Journal of Gastrointestinal Oncology

Original Article

Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy
Bei Wang, Zixuan Wang, Chuanhai Xu, Yueqin Wang, Honglan Gao, Haiping Liu, Mingyue Zheng, Zhenyuan Jiang, Zini Zhou, Gui Liu, Wei Geng
Hyperthermic intraperitoneal chemotherapy plus SOX chemotherapy versus SOX chemotherapy alone in patients with gastric cancer and peritoneal metastasis: a phase II randomized clinical trial
Lijie Luo, Zijing Zhang, Haiping Zeng, Yuting Xu, Yaohui Peng, Haipeng Huang, Zeyu Lin, Wenjun Xiong, Wei Wang
The role of TMSB15A in gastric cancer progression and its prognostic significance
Xiaolei Zhang, Xiang Yu, Qicheng Shen, Xiaohui Jiang, Yuan Zhou, Qiu Xue, Guangxin Cao
The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study
Chen Liang, Hai-Dong Liu, Han-Yi He, Ken Chen, Yi-Xing Huang, Dan Zu, Qi-Mei Bao, Yang-Chan Hu, Guo-Xia Liu, Chun-Kai Zhang, Yu-Ke Zhong, Ming-Cong Deng, Yan-Hua He, Ji Jing, Yin Shi, Zu Ye, Xiang-Dong Cheng
Predictive models of lymph node metastasis in patients with gastrointestinal stromal tumors based on machine learning algorithms: a SEER-based retrospective study
Zheng Lin, Jianping Xiong, Caixin Feng, Shaochun Pang, Liangxue Lin, Feiran Zhang, Xun Chen, Yuandong Yuan, Peijie Xie, Ting Wu, Yanchong Li, Peihong Zheng, Haijie Xu, Ziqun Liao
Expression of Claudin18.2 in metastatic lesions in peritoneum of gastric cancer
Akira Saito, Hideyuki Ohzawa, Rie Kawashima, Shiro Matsumoto, Kentaro Kurashina, Shin Saito, Hideyo Miyato, Yoshinori Hosoya, Naohiro Sata, Joji Kitayama, Hironori Yamaguchi
Development of a prognostic risk model for colorectal cancer and association of the prognostic model with cancer stem cell and immune cell infiltration
Jian Zhang, Peter C. Ambe, Aasma Shaukat
Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases
Vlasios S. Sotirchos, Mikhail T. Silk, Juan C. Camacho, Emma M. Schatoff, Henry S. Kunin, Erica S. Alexander, Ken Zhao, Louise C. Connell, Constantinos T. Sofocleous, Nancy E. Kemeny
“Budding”—an early MRI feature established in a case-control study of perianal fistula mucinous adenocarcinoma
Lillian Reza, Alison Corr, Philip Tozer, John T. Jenkins, Anthony Antoniou, Elaine M. Burns, David Burling, Ailsa Hart, Sue K. Clark, Phillip Lung
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage
Jiahao Zhou, Tinghan Yang, Xiangbing Deng, Ziqiang Wang
Identification of a pyroptosis-related gene prognostic signature in patients with hepatocellular carcinoma
Ruipeng Chen, Nuojie Luo, Pansong Li, Mengmeng Song, Liyan Ji, Xuan Gao, Xuefeng Xia, Mario Capasso, Yi Sun
Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance
Jun Zhou, Na Gao, Xin Tian, Yan Fang, Jie Gao, Qiang Wen, Ming-Zhu Cui, Yun-Fei Zhang, Sai-Fei Li, Lin-Jing Jia, Hai-Ling Qiao
Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features
Yongfei He, Qiang Gao, Shutian Mo, Ketuan Huang, Yuan Liao, Tianyi Liang, Meifeng Chen, Jicai Wang, Qiang Tao, Guangquan Zhang, Fenfang Wu, Chuangye Han, Xianjie Shi, Tao Peng
Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma
Yu Yao, Xiang Nong, Jing-Chang Liang, Yu-Mei Zhang, Zhi-Ming Zhang
PRMT5 attenuates regorafenib-induced DNA damage in hepatocellular carcinoma cells through symmetric dimethylation of RPL14
Wendi Bi, Xiaojuan Sun, Qiuyun Yi, Xinyu Jiang, Huisi He, Lixuan Jiang, Zhecai Fan, Hailing Huang, Wen Wen, Xiaoqing Jiang
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
Yue Hu, Xiong-Ying Jiang, Xi Cai, Song Chen, Qi-Feng Chen, Jun-Zhe Yi, Sui-Xing Zhong, Jiong-Liang Wang, Jie Xu, Gen-Jun Tan, Ning Lyu, Ming Zhao
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma
Chirayu Mohindroo, Paul S. Dy, Suraj P. Hande, Christopher R. D’Adamo, Arun Mavanur, Asha Thomas, Florencia McAllister, Ana De Jesus-Acosta
A novel nebulized drug delivery system based on an innovative high-pressure peristaltic pump availably applied to pressurized intraperitoneal aerosol chemotherapy
Renjie Li, Qiming Fan, Xiaosong Lin, Ruijian Chen, Bingcong Luo, Zifeng Yang, Yong Li
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes
Qianrong Wang, Xiangxu Wang, Zhenghua Shi, Yue Yang, Liping Ai, Hongmei Zhang, Jingyue Yang
Construction and validation of a nomogram model for predicting peritoneal metastasis in gastric cancer based on ferroptosis-relate genes and clinicopathological features
Xiaotong Sun, Kaipeng Duan, Xiaochun Shen, Chao Dong, Yajing Zhou, Tao Chen, Weikang Li, Peiyuan Li, Pengbo Wang, Dongbao Li, Jin Zhou